Metabolic Research, Inc. (OTC:MTBR), makers of Stemulite^TM, will have a booth in the Olympia Expo at the Las Vegas Convention Center South Hall, September 25^th and 26^th. The Stemulite^TM booth will feature Corey and Paul Simpson, well-known super athlete trainers joined by Cristi Cuellar, Miss Bikini Mexico International Elite Champion. They will sign autographs and explain the benefits and features of Stemulite^TM. Paul and Corey conducted the first life studies of Stemulite^TM on both male and female groups.

Corey Simpson, whose credits include 1999 Mr. Florida, 2001 NPC Jr Nationals Championship and 2006 Muscle Mania Superbody Men’s Posing Champion, reported that the rapid increase in strength and stamina were the most evident effects. This was confirmed by chiropractor Dr Todd J Cielo, D.C. who is also an ironman Tri-Athlete. Paul Simpson, Corey’s uncle and an NFL, Baseball and Professional Boxer trainer, conducted studies for MTBR to confirm Stemulite^TM health benefits.

The principle distinction between the men’s formula and the women’s formula is a component designed to preserve the fibroglandular tissue in women’s breasts, while diminishing the adipose fat tissue in the belly, hips and thighs.

The product is binary meaning there is one formula for morning and another for evening. In part, they work by recruiting stem cells from bone marrow to replace dead tissues and reduce soreness from exercise. The formulated compound achieves the greatest degree of stem cell activity at night by inducing increased quality REM sleep.

This press release includes "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In addition to statements which explicitly describe such risks and uncertainties, readers are urged to consider statements labeled with the terms "believes," "belief," "expects," "intends," "anticipates," "will," or "plans" to be uncertain and forward-looking. The forward-looking statements contained herein are also subject generally to other risks and uncertainties that are described from time to time in the company's reports and registration statements filed with the Securities and Exchange Commission.